Table 2.
Observed means at each assessment and results of unconditional linear growth curve models evaluating change in each outcome measure over time
| Pre-Tx(n = 80)a |
Midpoint(n = 54) |
Post-treatment(n = 44) |
3-month FU(n = 40) |
Fixed effect of time(intent to treat analyses) |
Effect sizeCohen’s d (95% CI) |
|||
|---|---|---|---|---|---|---|---|---|
| Outcome measure | Mean(SD) | Mean(SD) | Mean(SD) | Mean(SD) | B(SE) | DfP-value | Pre–Post | Pre-3-month FU |
| Total PCL-5 | 52.91 (14.51) |
44.81 (16.65) |
40.05 (17.01) |
41.05 (17.82) |
−4.42 (0.95) |
40.56 <0.001 |
0.89 (0.64–1.13) |
0.82 (0.57–1.06) |
| Total PHQ-9 | 16.09 (5.25) |
13.76 (5.26) |
12.11 (5.50) |
13.10 (5.75) |
−1.20 (0.32) |
40.08 0.0005 |
0.76 (0.54–0.97) |
0.57 (0.31–0.83) |
| Total DERS | 116.40 (23.61) |
103.39 (21.55) |
95.45 (20.27) |
96.53 (21.15) |
−7.37 (1.33) |
41.76 <0.0001 |
0.89 (0.53–1.15) |
0.84 (0.57–1.13) |
| Mean IIP-32 | 1.86 (0.44) |
1.70 (0.50) |
1.59 (0.56) |
1.57 (0.64) |
−0.11 (0.03) |
42.10 0.002 |
0.61 (0.36–0.86) |
0.66 (0.39–0.93) |
| AWHODAS-2.0 Overall |
49.31 (0.44) |
40.48 (16.16) |
39.27 (14.68) |
40.66 (19.88) |
−3.25 (1.00) |
42.50 0.002 |
0.68 (0.44–0.91) |
0.58 (0.36–0.81) |
| Getting along with people |
9.26 (3.61) |
7.17 (3.63) |
6.82 (3.50) |
7.03 (4.24) |
−0.82 (0.24) |
45.46 0.0014 |
0.68 (0.42–0.93) |
0.62 (0.33–0.90) |
| Participation in society |
10.05 (3.53) |
8.33 (3.87) |
7.57 (3.40) |
8.58 (4.20) |
−0.63 (0.24) |
44.02 0.01 |
0.74 (0.52–0.96) |
0.52 (0.23–0.81) |
| Life Activities | 17.61 (8.38) |
14.17 (7.79) |
15.21 (7.33) |
14.48 (9.33) |
−1.01 (0.51) |
43.17 (0.054) |
0.29 (0.06–0.51) |
0.37 (0.17–0.58) |
an = 80, with the exception of the AWHODAS-2.0 where n = 62 at pretreatment, 42 at midpoint, 33 at post, and 29 at 3-month follow-up.
PCL-5, Posttraumatic Stress Disorder Checklist for DSM-5; PHQ-9, Patient Health Questionaire-9 items; DERS, Difficulties n Emotion Regulation Scale; AWHODAS-2, Abbreviated World Health Organization Disability Assessment 2.0.